None
Conditions
Sponsors
MORINAGA & CO., LTD.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Japanese men aged 20-40 years. 2) Individuals who are healthy and are not suffered from a chronic malady. 3) Individuals whose written informed consent has been obtained. 4) Individuals who can visit an inspection facility and be inspected in designated days. 5) Individuals judged appropriate for the study by the principal. 6) Individuals who are not resistant to blood sampling.
Exclusion criteria
Exclusion criteria: 1)Individuals using medical products. 2)Individuals who have a history of serious hepatopathy, kidney damage, heart disease, lung and blood disease. 3)Individuals who contract or have a history of serious gastrointestinal disease. 4)Individuals who have an addiction to alcohol or a mental illness. 5)Individuals who used or applied a drug for treatment of disease in the past 1 month. 6)Individuals with probable seasonal allergy, such as pollinosis, during the test period.(In particular, Betulaceae: alder, oba alnus firma, shirakaba, Taxodiaceae: cryptomeria, hinoki cypress, Asteraceae: ragweed, Artemisia vulgaris indica, Gramineae:Dactylis glomerata, Phleum pratense) 7)Individuals who have possibility of allergy symptoms onset by the test food and who cause severe allergic symptoms in foods and medicines. 8)Individuals cannnot drink milk,dairy products or soy milk. 9)Individuals with serious anemia. 10)Individuals with high blood glucose(fasting blood glucose over 126mg/dL). 11)Individuals who are a smoker. 12)Individuals whose life style will change during the test period. 13)Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period. 14)Individuals who were hospitalized and received treatment in the past 6 months. 15)Individuals who participated in other clinical studies in the past 1 months or will participate in other clinical studies during the test period. 16)Individuals judged inappropriate for the study by the principal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma amino acids concentration | — |
Secondary
| Measure | Time frame |
|---|---|
| plasma glucose and insulin concentration | — |
Countries
Japan
Contacts
Public ContactMai Wajiki
MORINAGA & CO., LTD. Health Science and Research Center, R&D institute
Outcome results
None listed